MARKET

CLSN

CLSN

Celsion
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.230
-0.160
-11.51%
After Hours: 1.230 0 0.00% 16:41 11/15 EST
OPEN
1.450
PREV CLOSE
1.390
HIGH
1.500
LOW
1.150
VOLUME
290.29K
TURNOVER
--
52 WEEK HIGH
2.630
52 WEEK LOW
1.050
MARKET CAP
26.31M
P/E (TTM)
-3.3478
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CLSN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CLSN News

  • Edited Transcript of CLSN earnings conference call or presentation 15-Nov-19 4:00pm GMT
  • Thomson Reuters StreetEvents.1d ago
  • Celsion Corporation (CLSN) CEO Michael Tardugno on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.1d ago
  • Celsion beats EPS consensus
  • seekingalpha.1d ago
  • Earnings Scheduled For November 15, 2019
  • Benzinga.1d ago

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About CLSN

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall breast cancer (the DIGNITY Study). Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. It has over three platform technologies for the development of treatments for those suffering with difficult-to-treat forms of cancer, including Lysolipid Thermally Sensitive Liposomes, a heat sensitive liposomal based dosage form that targets disease with known therapeutics in the presence of mild heat; TheraPlas, a nucleic acid-based treatment for local transfection of therapeutic plasmids, and TheraSilence, a systemic dosage form for lung directed anti-cancer ribonucleic acid (RNA).
More

Webull offers Celsion Corporation (CLSN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.